Hospira Logo (Potassium 01)
Potassium Chloride Injection, Solution, Concentrate
Product Images NDC 0409-6635
9 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 0409-6635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (5 mL Vial Label)
Potassium Chloride Injection Concentrate, USP 10 mEq/5 mL (2 mEq/mL) vial label. The label indicates the product is a single-dose 5 mL concentrate for intravenous use, requiring dilution before use. It includes details such as the active ingredient strength, lot and expiration placeholders, NDC 0409-6635-18, and is distributed by Hospira, Inc., Lake Forest, IL.*
Principal Display Panel (5 mL Vial Tray)
Potassium Chloride injection concentrate USP label for intravenous use, 10 mEq/5 mL (2 mEq/mL) strength. This single-dose 5 mL vial carton from Hospira, Inc. includes storage instructions, aseptic technique guidance, and dilution warning. The label shows NDC 0409-6635-01 with barcode and clear usage instructions.*
Principal Display Panel (10 mL Vial Label)
Label for Potassium Chloride Injection Concentrate USP 20 mEq/10 mL (2 mEq/mL) by Hospira, Inc. The label states it is a 10 mL single-dose intravenous solution that must be diluted before use. It includes dosage strength details, storage, and usage instructions, along with the lot and expiration placeholders.*
Principal Display Panel (10 mL Vial Tray)
Potassium Chloride 20 mEq/10 mL (2 mEq/mL) injection concentrate label for intravenous use by Hospira, Inc. The label states it is a single-dose 10 mL vial concentrate that must be diluted before use. The product contains 149 mg/mL potassium chloride and is intended for intravenous infusion only. Storage instructions and usage precautions are included on the label.*
Principal Display Panel (20 mL Vial Label)
Label for Potassium Chloride for Injection, Concentrate, USP 40 mEq/20 mL (2 mEq/mL) intravenous solution. The label indicates single-dose use, prescription only, distributed by Hospira, Inc. It includes a warning to dilute before use, and states composition details including potassium chloride concentration and sterility.*
Principal Display Panel (20 mL Vial Tray)
Potassium Chloride injection concentrate, USP 40 mEq/20 mL (2 mEq/mL) in a 20 mL single-dose vial label by Hospira, Inc. The label includes a warning that the concentrate must be diluted before use and indicates intravenous administration. Storage and aseptic technique instructions are also present.*
Principal Display Panel (15 mL Vial Label)
Label for Potassium Chloride Injection Concentrate, USP 30 mEq/15 mL (2 mEq/mL) by Hospira, Inc. It is a 15 mL single-dose vial for intravenous use, labeled as concentrate that must be diluted before use. The label includes strength details, storage, and usage instructions alongside the NDC 0409-6636-18 and the Hospira logo.*
Tray Ndc 0409-6636-01 (Potassium 09)
Potassium Chloride 30 mEq/15 mL (2 mEq/mL) Injection Concentrate label for intravenous use by Hospira, Inc. The package contains 15 mL single-dose units. The label states it must be diluted before use and includes storage, usage directions, and the NDC 0409-6636-01.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
